PMID: 42487672
Effects of combined metformin and cabergoline versus metformin alone on inflammatory markers in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial.
Hamad Inas Naser, Kadhim Sinaa Abdul Amir, Bassim Mohammad, Asma Swadi, Adnan Fawzi Hayder
Journal of medicine and life · 2026
Vol. 19, Issue 5, pp. 359-365
This entry links to third-party literature. For research use only.
HumansFemaleMetforminPolycystic Ovary SyndromeHyperprolactinemiaCabergolineDrug Therapy, CombinationBiomarkersErgolinesAdult